The short answer is yes—infants can develop sinus infections, but it’s not common. Unlike older children or adults, babies are born with only two sets of sinuses: the ethmoid sinuses (between the eyes ...

You may be reading this because you or someone you care about has nasal cavity or sinus cancer. Learning more can help you get ready to talk with your healthcare provider and understand the next steps ...

Researchers at the University of California San Diego and the Veterans Affairs San Diego Healthcare System have identified a distinct biological pattern of chronic rhinosinusitis (CRS), a chronic ...

As sniffle season sets in, sinus infections are among the most common illnesses seen in doctors’ offices. For most people, they’re nothing more than an inconvenience and a few days of congestion, but, ...

Oct 17 (Reuters) - The U.S. Food and Drug Administration has approved Amgen (AMGN.O), opens new tab and AstraZeneca's (AZN.L), opens new tab drug for a type of chronic inflammatory sinus disease, the ...

Add Yahoo as a preferred source to see more of our stories on Google. An Amgen sign is seen at the company's headquarters in Thousand Oaks, California, U.S., November 6, 2019. REUTERS/Deena Beasley By ...

Dear Doctors: My nose has been plugged up for a few weeks from a sinus infection. Now my left ear is feeling full, and sounds are muffled. Can that be related? My dad says yes. (He has GERD, and he ...

Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by University College London (UCL) along with academics at the University ...

Mucormycosis emerges as a critical concern in diabetic patients with sudden vision loss, highlighting the need for prompt diagnosis and treatment. A recent report published by Turkish investigators ...

Treatment with LYR-120 was associated with a statistically significant improvement over sham in the composite of 3 cardinal symptoms of CRS at week 24 in patients without nasal polyps. Topline results ...

GSK's Nucala approved in China for CRSwNP, affecting 1/3 of 107 million sinusitis patients; third IL-5 condition indication in the region. Phase 3 trial shows Nucala reduces COPD exacerbations; FDA ...